Your browser doesn't support javascript.
loading
Merkel cell carcinoma in Taiwan: A rare tumour with a better prognosis in those harbouring Merkel cell polyomavirus.
Chen, S W; Chang, S T; Ho, C H; Wang, J S; Wang, R C; Takeuchi, K; Chuang, S S.
Affiliation
  • Chen SW; Lioying Chi-Mei Hospital, Department of Internal Medicine, Division of Hemato-Oncology, Tainan, Taiwan.
  • Chang ST; Lioying Chi-Mei Hospital, Department of Pathology, Tainan, Taiwan.
  • Ho CH; Lioying Chi-Mei Hospital, Chi-Mei Medical Center, Medical Research, Tainan, Taiwan.
  • Wang JS; Kaohsiung Veterans General Hospital, Department of Pathology and Laboratory Medicine, Kaohsiung, Taiwan.
  • Wang RC; China Medical University Hospital, Department of Pathology, Taichung, Taiwan and HungKuang University, College of Nursing, Department of Nursing, Taichung, Taiwan.
  • Takeuchi K; The Cancer Institute, Pathology Project for Molecular Targets and The Cancer Institute Hospital, Division of Pathology, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Chuang SS; Lioying Chi-Mei Hospital, Department of Pathology, Tainan, Taiwan.
Malays J Pathol ; 44(1): 61-66, 2022 Apr.
Article de En | MEDLINE | ID: mdl-35484887
ABSTRACT
Merkel cell carcinoma (MCC) is a rare malignant cutaneous neuroendocrine tumour affecting mainly elderly patients and is more common in the West than in Asia. It is associated with Merkel cell polyomavirus (MCPyV), immunosuppression, and ultraviolet light. In this study, we retrospectively investigated the first series of MCC from Taiwan and identified 19 cases from three tertiary centres. All patients were males with a median age of 67.5. Twelve (63%) cases occurred in the extremities, with one unique case presenting initially as nodal metastasis of unknown primary. Immunohistochemically, the great majority of tumours expressed CK20 (89%), synaptophysin (89%), and INSM1 (84%), with none positive for TTF1. Eleven (58%) cases were positive for MCPyV by immunohistochemistry (clone CM2B4). All patients were treated with excision, including four with additional radiotherapy and one with radiotherapy and chemotherapy. Nodal status and treatment modalities significantly affected survival. The median survival time of MCPyV-positive cases was much longer than the negative cases (median 40 vs. 10 months). In summary, we presented the first report on the clinicopathological features of MCC in Taiwan, with 58% cases associated with MCPyV. The prognosis of patients with MCPyV-positive tumours was better than those negative for MCPyV.
Sujet(s)
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Carcinome à cellules de Merkel / Infections à polyomavirus / Polyomavirus des cellules de Merkel Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male Pays/Région comme sujet: Asia Langue: En Journal: Malays J Pathol Année: 2022 Type de document: Article Pays d'affiliation: Taïwan
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Carcinome à cellules de Merkel / Infections à polyomavirus / Polyomavirus des cellules de Merkel Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male Pays/Région comme sujet: Asia Langue: En Journal: Malays J Pathol Année: 2022 Type de document: Article Pays d'affiliation: Taïwan